Biomedical Journal
The Incretin Revolution: Integrating Incretin-Based Therapies into Clinical Care

ReviewInterventions
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Cardiovascular disease
- Chronic kidney disease
- Metabolic dysfunction-associated steatotic liver disease
- Humans
The paper
Yale University; University of California San Diego
Biomedical Journal, 14 Sep 2026
